Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Explainable machine learning for preoperative relapse prediction in molecularly stratified endometrial cancer: A single-center finnish cohort study. Local targets link to admitted publications; unresolved targets remain external evidence.
Molecular classification of endometrial carcinoma applied to endometrial biopsy specimens: towards early personalized patient management
10.1016/j.ygyno.2019.06.012 · 2019 · External reference
Mismatch repair deficiency identifies patients with high-intermediate–risk (HIR) endometrioid endometrial cancer at the highest risk of recurrence: a prognostic biomarker
10.1002/cncr.31901 · 2018 · External reference
10.1016/j.csbj.2023.10.033 · Admitted local publication
Reactivity of a monoclonal antibody with human ovarian carcinoma
10.1172/jci110380 · 1981 · External reference
Surveillance strategies in endometrial cancer care: why less represents progress
10.1200/jco.22.01551 · 2022 · External reference
FIGO staging of endometrial cancer: 2023
10.1002/ijgo.14923 · 2023 · External reference
A radiomic-based machine learning model predicts endometrial cancer recurrence using preoperative CT radiomic features: a pilot study
10.3390/cancers15184534 · 2023 · External reference
Uterine carcinosarcoma: a review of the literature
10.1016/j.ygyno.2015.03.041 · 2015 · External reference
Pattern of recurrence in endometrial cancer. The murderer always returns to the scene of the crime
2024 · External reference
10.1016/j.csbj.2023.11.008 · Admitted local publication
Racial and Ethnic differences in hysterectomy-corrected uterine corpus cancer mortality by stage and histologic subtype
10.1001/jamaoncol.2022.0009 · 2022 · External reference
ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma: update 2025
10.1016/s1470-2045(25)00167-6 · 2025 · External reference
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
10.1136/ijgc-2020-002230 · 2021 · External reference
Development and validation of a prognostic nomogram model incorporating routine laboratory biomarkers for preoperative patients with endometrial cancer
10.1186/s12885-023-11497-8 · 2023 · External reference
10.1038/s41591-018-0177-5
10.1038/s41591-018-0177-5 · External reference
Endometrial cancer
10.1016/s0140-6736(22)00323-3 · 2022 · External reference
Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practice
2023 · External reference
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial
10.1016/s1470-2045(19)30395-x · 2019 · External reference
Randomized phase II trial of carboplatin–paclitaxel compared with carboplatin–paclitaxel–trastuzumab in advanced (Stage III–IV) or recurrent uterine serous carcinomas that overexpress Her2/Neu (NCT01367002): updated overall survival analysis
10.1158/1078-0432.ccr-20-0953 · 2020 · External reference
10.1200/jco.2017.76.5966
10.1200/jco.2017.76.5966 · External reference
Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts
10.1016/s2589-7500(22)00210-2 · 2023 · External reference
10.1038/s43018-020-0085-8
10.1038/s43018-020-0085-8 · External reference
10.1016/j.annonc.2024.02.006
10.1016/j.annonc.2024.02.006 · External reference
2023 FIGO staging system for endometrial cancer: the evolution of the revolution
10.1016/j.ygyno.2024.02.002 · 2024 · External reference
2020 WHO classification of female genital tumors
10.1055/a-1545-4279 · 2021 · External reference
Biomarker-driven therapy in endometrial cancer
10.1136/ijgc-2022-003676 · 2023 · External reference
Risk stratification of endometrial cancer patients: FIGO stage, biomarkers and molecular classification
10.3390/cancers13225848 · 2021 · External reference
Unresolved reference
2025 · External reference
Low expression of stanniocalcin 1 (STC-1) protein is associated with poor clinicopathologic features of endometrial cancer
10.3389/pore.2021.1609936 · 2021 · External reference
American society of anesthesiologists physical status score as a predictor of long-term outcome in women with endometrial cancer
10.1136/ijgc-2018-000118 · 2019 · External reference
Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series
10.1093/annonc/mdy058 · 2018 · External reference
Improved prognostic stratification with 2023 international federation of gynecology and obstetrics staging in endometrial cancer reflecting poor prognosis of aggressive histological types and p53 abnormality
10.1016/j.labinv.2025.104189 · 2025 · External reference
Pattern of recurrence of the molecular subgroups in stage I high-grade endometrial cancer
10.1016/j.ygyno.2025.04.576 · 2025 · External reference
Update in the molecular classification of endometrial carcinoma
10.1136/ijgc-2022-003772 · 2023 · External reference
10.1002/path.5373
10.1002/path.5373 · External reference
10.1038/nature12113
10.1038/nature12113 · External reference
Predicting recurrence risk in endometrial cancer: a multisequence MRI intratumoral and peritumoral radiomics nomogram approach
2025 · External reference
Unresolved reference
2025 · External reference
10.1002/jcb.26109
10.1002/jcb.26109 · External reference
10.1016/j.csbj.2024.06.035
10.1016/j.csbj.2024.06.035 · External reference
ENDORISK-2: a personalized Bayesian network for preoperative risk stratification in endometrial cancer, integrating molecular classification and preoperative myometrial invasion assessment
10.1016/j.ejca.2025.116058 · 2025 · External reference
Distinct clinical outcomes according to molecular subgroups in relapsed endometrial carcinoma: a cohort study
10.1016/j.ygyno.2025.08.031 · 2025 · External reference
Molecular subgroup-specific prognostic value of semiquantitative lymphovascular space invasion in early-stage endometrioid endometrial cancer
10.1016/j.ygyno.2025.04.589 · 2025 · External reference
Clinicopathologic vs. molecular integrated prognostication of endometrial carcinoma by european guidelines
10.3390/cancers14030651 · 2022 · External reference
Unresolved reference
2017 · External reference
10.1016/j.csbj.2024.01.024 · 2024 · Admitted local publication
Comprehensive review of endometrial cancer: new molecular and FIGO classification and recent treatment changes
10.3390/jcm14041385 · 2025 · External reference
High-grade endometrial carcinomas
10.1097/pgp.0000000000000491 · 2019 · External reference
Machine learning and mechanistic modeling for prediction of metastatic relapse in early-stage breast cancer
10.1200/cci.19.00133 · 2020 · External reference
Current and emerging prognostic biomarkers in endometrial cancer
10.3389/fonc.2022.890908 · 2022 · External reference
A multicentre study of reference intervals for haemoglobin, basic blood cell counts and erythrocyte indices in the adult population of the Nordic countries
10.1080/00365510410002797 · 2004 · External reference
Preoperative molecular classification of endometrial cancer: validation through biopsy and matched hysterectomy specimens
10.1016/j.ygyno.2025.10.026 · 2025 · External reference
Endometrial cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up
10.1016/j.annonc.2022.05.009 · 2022 · External reference
Prediction of endometrial cancer recurrence by using a novel machine learning algorithm: an Israeli gynecologic oncology group study
10.1016/j.jogoh.2022.102466 · 2022 · External reference
Addressing the role of obesity in endometrial cancer risk, prevention, and treatment
10.1200/jco.2016.69.4638 · 2016 · External reference
PD-L1 expression in endometrial carcinoma cells and intratumoral immune cells
10.1097/pas.0000000000001395 · 2019 · External reference
Differential impact of clinicopathological risk factors within the 2 largest ProMisE molecular subgroups of endometrial carcinoma
10.1371/journal.pone.0253472 · 2021 · External reference
Clinicopathological significance of deficient DNA mismatch repair and MLH1 promoter methylation in endometrioid endometrial carcinoma
10.1038/s41379-020-0501-8 · 2020 · External reference
L1 Cell adhesion molecule as a predictor of disease-specific survival and patterns of relapse in endometrial cancer
10.1097/igc.0000000000000801 · 2016 · External reference
Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium
10.1016/j.ijgo.2009.02.012 · 2009 · External reference
10.1016/j.csbj.2023.03.046 · Admitted local publication
Predicting recurrence and recurrence-free survival in high-grade endometrial cancer using machine learning
10.1002/jso.27008 · 2022 · External reference
Practical guide to SHAP analysis: explaining supervised machine learning model predictions in drug development
10.1111/cts.70056 · 2024 · External reference
OncoProExp: an interactive shiny web application for comprehensive cancer proteomics and phosphoproteomics analysis
2025 · External reference
Molecular classification of endometrial carcinoma on endometrial biopsy: an early prognostic value to guide personalized treatment
10.1136/ijgc-2024-005478 · 2024 · External reference
β-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype
10.1097/01.mp.0000028573.34289.04 · 2002 · External reference
Cancer statistics, 2022
2022 · External reference
Time to first recurrence, pattern of recurrence, and survival after recurrence in endometrial cancer according to the molecular classification
10.1016/j.ygyno.2022.02.024 · 2022 · External reference
Tumor size, an additional risk factor of local recurrence in low-risk endometrial cancer: a large multicentric retrospective study
10.1097/igc.0000000000001223 · 2018 · External reference
A clinically applicable molecular-based classification for endometrial cancers
10.1038/bjc.2015.190 · 2015 · External reference
Confirmation of ProMisE: a simple, genomics-based clinical classifier for endometrial cancer
10.1002/cncr.30496 · 2017 · External reference
10.3390/ijms252111448
10.3390/ijms252111448 · External reference
10.1038/s41568-019-0177-x
10.1038/s41568-019-0177-x · External reference
Prediction of recurrence risk in endometrial cancer with multimodal deep learning
2024 · External reference
FIGO 2023 endometrial cancer staging: too much, too soon?
10.1136/ijgc-2023-004981 · 2023 · External reference
10.1016/j.csbj.2023.10.025
10.1016/j.csbj.2023.10.025 · External reference
Prediction of endometrial carcinoma using the combination of electronic health records and an ensemble machine learning method
2022 · External reference
The role of metabolic syndrome in endometrial cancer: a review
2019 · External reference
10.1016/j.ygyno.2023.06.008
10.1016/j.ygyno.2023.06.008 · External reference
Outcome and predictive factors in uterine carcinosarcoma using postoperative radiotherapy: a rare cancer network study
10.4081/rt.2016.6052 · 2016 · External reference
